Condition: Ascites Hepatic · Liver Failure · Cirrhosis, Liver · Sponsor: Carol Davila University of Medicine and Pharmacy
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
This description comes directly from the study's public registry record.
Mihai Ciocirlan · 0040722322625 · ciocirlanm@yahho.com
Always discuss trial participation with your own doctor first.
| "Agrippa Ionescu" Hospital | Bucharest, Romania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06224023